38694-04-1

Basic information

• Product Name: Benzene, 1-fluoro-3-[(1E)-2-(4-nitrophenyl)ethenyl]-
• CAS NO: 38694-04-1
• Molecular Formula: C14H10FNO2
• Molecular Weight: 243.237
• Mol File: 38694-04-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzene, 1-fluoro-3-[(1E)-2-(4-nitrophenyl)ethenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-fluoro-3-[(1E)-2-(4-nitrophenyl)ethenyl]-(38694-04-1)
• EPA Substance Registry System: Benzene, 1-fluoro-3-[(1E)-2-(4-nitrophenyl)ethenyl]-(38694-04-1)

Safety Data

• Hazardous Substances Data: 38694-04-1(Hazardous Substances Data)

Upstream product

• 104097-04-3 1-(diethoxyphosphorylmethyl)-3-nitro-benzene 
• 456-48-4 3-Fluorobenzaldehyde 
• 2609-49-6 diethyl p-nitrobenzylphosphonate 

Downstream Products

• 38693-98-0 (E)-4-[2-(3-fluoro-phenyl)-vinyl]-phenylamine 

Relevant articles and documents

Inhibition of monoamine oxidase by (E)-styrylisatin analogues

Previous studies have shown that (E)-8-(3-chlorostyryl)caffeine (CSC) is a specific reversible inhibitor of human monoamine oxidase B (MAO-B) and does not bind to human MAO-A. Since the small molecule isatin is a natural reversible inhibitor of both MAO-B

N-acylamino benzyl ether derivatives

This invention relates to N-acylamino aryl derivatives of the formula 1where R1, R21, R22, R23, R3, R4, R5 R6, R7, R8, R, and n are as defined herein and where X is —CHRO, —OCHR—, —CH2S—, —SCH2—, —CH2CH2—, —CH=CH— or —C≡C—. The compounds of the invention are selective monoamine oxidase B inhibitors, and they are therefore useful in the treatment of diseases mediated by monoamine oxidase B, for example, for the treatment of Alzheimer's disease or senile dementia.